Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas. (Q53573964)

15 May 2018

title

Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas. (English)

1 reference

15 May 2018

author name string

Je-Jung Lee

1

1 reference

15 May 2018

Dong Hwan Kim

2

1 reference

15 May 2018

Nan Young Lee

3

1 reference

15 May 2018

Sang Kyun Sohn

4

1 reference

15 May 2018

Jong Gwang Kim

5

1 reference

15 May 2018

Hyeoung-Joon Kim

6

1 reference

15 May 2018

Young Rok Do

7

1 reference

15 May 2018

Yeon Hee Park

8

1 reference

15 May 2018

language of work or name

English

0 references

publication date

4 April 2007

1 reference

15 May 2018

British Journal of Haematology

published in

1 reference

15 May 2018

volume

137

1 reference

15 May 2018

issue

4

1 reference

15 May 2018

page(s)

329-336

1 reference

15 May 2018

Correlation of serum IL-2, IL-6 and IL-10 levels with International Prognostic Index in patients with aggressive non-Hodgkin's lymphoma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Immunohistochemical expression of IL-10 in mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Interleukin-10 in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

A review of the association between interleukin-10 and human B-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Haplotype associated with low interleukin-10 production in patients with severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Comprehensive analysis of genetic polymorphisms in the interleukin-10 promoter: implications for immune regulation in specific ethnic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

T-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Expression of HLA class I, beta(2)-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK/T-cell lymphoma: Implications for tumor immune escape mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

A New Statistical Method for Haplotype Reconstruction from Population Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

Elevated Serum Levels of IL-10 are Associated with Inferior Progression-Free Survival in Patients with Hodgkin's Disease Treated with Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06570.X

10.1111/J.1365-2141.2007.06570.X

21 January 2018

Identifiers

DOI

1 reference

15 May 2018

PubMed ID

17408400

1 reference

15 May 2018